Braskem S.A. Website

Braskem S.A.

BOVESPA-BRKM5

Company Overview

Braskem S.A., together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells chemicals, including ethylene, polymer and chemical grade propylene, butadiene, butene-1, benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins. This segment also produces and sells polyethylene (PE) and polypropylene (PP); supplies electricity and other inputs to second-generation producers; produces and sells of PE, including the production of green PE from renewable resources; and produces and sells polyvinyl chloride and caustic soda. The United States and Europe segment produces and sells PP in the United States and Germany. The Mexico segment produces and sells ethylene, high-density PE, and low-density PE in Mexico. It also manufactures, sells, imports, and exports chemicals, petrochemicals, and fules; produces, supplies, and sells utilities, such as steam, water, compressed air, and industrial gases; and provides industrial services. The company was formerly known as Copene Petroquímica do Nordeste S.A. and changed its name to Braskem S.A. in 2002. Braskem S.A. was founded in 1972 and is headquartered in Camaçari, Brazil.

  • Name

    Braskem S.A.

  • CEO

    Roberto Prisco Paraíso Ramos

  • Website

    www.braskem.com.br

  • Sector

    Chemicals

  • Year Founded

    1972

Company Statistics

Profile

  • Market Cap

    —

  • EV

    —

  • Shares Out

    —

  • Revenue

    —

  • Employees

    —

Margins

  • Gross

    —

  • EBITDA

    —

  • Operating

    —

  • Pre-Tax

    —

  • Net

    —

  • FCF

    —

Returns (5Yr Avg)

  • ROA

    —

  • ROTA

    —

  • ROE

    —

  • ROCE

    —

  • ROIC

    —

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    —

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    —

  • Net Debt

    —

  • Debt/Equity

    —

  • EBIT/Interest

    —

Growth (CAGR)

  • Rev 3Yr

    —

  • Rev 5Yr

    —

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    —

  • Dil EPS 5Yr

    —

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    —

  • EBITDA Fwd 2Yr

    —

  • EPS Fwd 2Yr

    —

  • EPS LT Growth Est

    —

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

What's happening

Nov 11, 2025 - Dec 11, 2025

Braskem SA's Stock Surge Driven by Strategic Moves and Positive Sentiment

  • Braskem is nearing a control transfer agreement between banks and Novonor, boosting investor confidence.
  • A potential sale of Novonor's controlling stake to IG4 generated significant stock price increases.
  • Legislative support from the Brazilian Congress enhanced growth prospects for Braskem.

Over the past month, Braskem SA (BAK) experienced a notable increase of 18.8%, significantly outperforming the S&P 500, which returned only 0.3%. This strong performance can be attributed to several key developments that positively influenced investor sentiment and stock movement. On November 14, reports indicated that Braskem was nearing an agreement with banks regarding the transfer of control from Novonor, resulting in a substantial price surge of approximately 13% on that day.

The momentum continued with further positive news on November 11 when Bloomberg reported that Novonor was considering selling its controlling stake in Braskem to IG4. This announcement led to another significant uptick in BAK's stock price by nearly 19%. These developments not only bolstered market confidence but also attracted attention from analysts who began upgrading their ratings following favorable resolutions concerning financial pressures in Alagoas.

However, there were moments of caution as well; on November 12, social media discussions highlighted uncertainty when Novonor denied any progress regarding negotiations for its controlling stake despite earlier optimism stemming from an Alagoas settlement resolution. Although this resulted in a minor decline of about 3%, it did not overshadow the overall bullish trajectory established earlier in the month.

On November 19, Bank of America raised its price target for Braskem after confirming legislative support through the passage of the PRESIQ bill within Brazilian Congress. This event contributed to another rise of approximately 3.9% during trading hours as shares reacted favorably to enhanced growth prospects linked with regulatory backing.

Overall, BAK's impressive performance over this one-month period reflects strong market dynamics driven by strategic corporate moves and supportive external factors while maintaining resilience against occasional bearish sentiments arising from uncertainties related to ownership negotiations. Notably, relative to sector performance metrics during this timeframe: Braskem SA outperformed the Materials (XLB) sector by an impressive margin of 67.7%.

BOVESPA:BRKM5